• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameAUTOPAP PRIMARY SCREENING SYSTEM
Classification Namereader, cervical cytology slide, automated
Generic Namecervical cytology device
ApplicantTRIPATH IMAGING
PMA NumberP950009
Supplement NumberS004
Date Received10/01/1999
Decision Date10/05/2001
Product Code
MNM[ Registered Establishments with MNM ]
Advisory Committee Pathology
Supplement Typenormal 180 day track
Supplement Reason labeling change - other
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for use of the device with autocyte prep cervical cytology slides. The device, as modified, will be marketed under the trade name autopap primary screening system and is indicated for: the autopap primary screening system is an automated cervical cytology screening device intended for use in initial screening of cervical cytology slides. The autopap primary screening system identifies up to 25% of successfully processed slides as requiring no further review. The autopap primary screening system also identifies at lease 15% of all successfully processed slides for a second manual review. The device is intended to be used on both conventionally-prepared and autocyte prep cervical cytology slides. For both preparation methods, the device is intended to detect slides with evidence of squamous carcinoma and adenocarcinoma and their usual precursor conditions; it is not intended to be used on slides designated by the laboratory as high risk. Intended users are trained cytology laboratory personnel operating under the direct supervision of a qualified cytology supervisor or laboratory manager/director.
-
-